Atlas Trials

Trial to Evaluate the Efficacy and Safety of IVIEW-1201 in Acute Bacterial Conjunctivitis

Clinical trial NCT05816070 · COMPLETED

Trial details

NCT number
NCT05816070
Sponsor
IVIEW Therapeutics Inc.
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Acute Bacterial Conjunctivitis
Start date
2023-01-05
Primary completion
2023-11-13
Enrollment
129

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.